MAPK14 and cardiac hypertrophy: Our data showed that Cdc42 deletion significantly reduced the phosphorylation of p38 in AngII-induced cardiac hypertrophy but did not affect the ERK or JNK pathways, which is consistent with the findings of Pellieux [29].